M49.3 – Spondylopathy in Diseases Classified Elsewhere
M49.3 is an ICD-10 code for spondylopathy in diseases classified elsewhere, describing spinal disorders that occur as a consequence of another underlying condition.
Things worth knowing about "M49.3"
M49.3 is an ICD-10 code for spondylopathy in diseases classified elsewhere, describing spinal disorders that occur as a consequence of another underlying condition.
What is M49.3?
The ICD-10 code M49.3 refers to spondylopathy in diseases classified elsewhere. This code is used when pathological changes affect the spine not as a primary condition, but as a secondary manifestation or complication of another diagnosed underlying disease. The term spondylopathy derives from the Greek words “spondylos” (vertebra) and “pathos” (suffering) and broadly describes any disease or disorder of the vertebral column.
Causes
Because M49.3 represents a secondary condition, its causes are always rooted in an underlying disease. Common underlying conditions that can lead to spondylopathy classified under M49.3 include:
- Infectious diseases: such as tuberculosis (Pott disease), brucellosis, or other bacterial infections that directly involve the vertebral bodies
- Metabolic disorders: including diabetes mellitus or gout, which can affect bone and joint tissue
- Systemic diseases: such as rheumatoid arthritis, systemic lupus erythematosus, or ankylosing spondylitis
- Malignant diseases: bone metastases or haematological malignancies that destroy vertebral structures
- Neurological conditions: such as syringomyelia or tabetic arthropathy, which secondarily affect the spine
Symptoms
Symptoms vary considerably depending on the underlying condition and the extent of spinal involvement. Common complaints include:
- Back pain, which may be localized or radiating
- Reduced range of motion and stiffness of the spine
- Neurological deficits such as numbness, tingling, or weakness in the arms or legs if nerve compression is present
- Postural changes or visible deformities of the spinal column
- General symptoms of the underlying disease (e.g., fever in cases of infection)
Diagnosis
Diagnosing spondylopathy under M49.3 requires identifying both the spinal changes and confirming the presence of the underlying disease. Typical diagnostic procedures include:
- Imaging: X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) to visualize vertebral changes
- Laboratory tests: complete blood count, inflammatory markers (CRP, ESR), infectious serology, and tumour markers as appropriate
- Bone biopsy: when infection or malignancy is suspected
- Neurological assessment: to evaluate potential nerve involvement
Treatment
Since M49.3 describes a secondary condition, treating the underlying disease is the primary therapeutic goal. In addition, the following measures may help address spinal symptoms:
- Pharmacological therapy: pain relief with analgesics or anti-inflammatory drugs, and targeted treatment of the cause (e.g., antibiotics for infectious spondylopathy)
- Physiotherapy and rehabilitation: to restore mobility, strengthen supporting musculature, and reduce disability
- Orthopaedic aids: such as braces or orthoses to support and offload the spine
- Surgical intervention: in cases of severe instability, nerve compression, or structural damage requiring operative stabilisation
Prognosis
The prognosis depends largely on the nature and course of the underlying disease. Early and consistent treatment of the root cause can often limit or even reverse spinal damage. In cases of severe structural changes, permanent functional impairment may remain.
References
- World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO Press.
- Firestein, G. S. et al.: Kelley and Firestein's Textbook of Rheumatology, 10th Edition. Elsevier, 2017.
- Mandell, G. L. et al.: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition. Elsevier, 2020.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMitochondrial repair
Immune cell maturation test
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: M49.3